Brief: HyBryte Clinical Results Demonstrate Continued Improvement Post-Treatment
02/12/2024 12:41
Dec 2 (Reuters) - Soligenix Inc SNGX.O :
* HYBRYTE™ CLINICAL RESULTS DEMONSTRATE CONTINUED
IMPROVEMENT
POST-TREATMENT
* SOLIGENIX: 1 OF 5 PATIENTS RECEIVING VALCHLOR HAD TO BE
WITHDRAWN FROM TRIAL DUE TO A CLINICALLY SIGNIFICANT ALLERGIC
CONTACT DERMATITIS
* SOLIGENIX INC: HYBRYTE WAS WELL TOLERATED IN ALL PATIENTS
Source text: ID:nPn5sZPg7a
Further company coverage: SNGX.O
((Reuters.Briefs@thomsonreuters.com;))